Chemed Analyst Price Targets - Benzinga

Chemed Corp

CHENYSE

Trade with Public

Trade with Public

$541.92

8.561.6%

Ult. Agg.: Oct 29, 4:00 PM

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Dividendi Confronta Opzioni Rapporto azionario

© 2026 Benzinga | All Rights Reserved

Chemed Analyst Price Targets - Benzinga

Chemed Analyst Price Targets

Wall Street analyst price targets and consensus rating for Chemed (CHE).

Price Target Range — 12 Quarters

Analyst Consensus — 5 Analysts

3Buy

2Hold

Consensus RatingBuy# Analysts5Avg. Consensus PT$603Upside to Avg. PT+11.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 29, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$548→$585
Oct 29, 2026	UBS	A.J. Rice	PT Raise	Buy	$650→$675
Oct 29, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$590→$625
Oct 28, 2026	Jefferies	Brian Tanquilut	Upgrade	Hold→Buy	$520→$620
Sep 25, 2026	UBS	A.J. Rice	Initiate	Buy	$650
Jul 31, 2026	Oppenheimer	Michael Wiederhorn	PT Raise	Outperform	$500→$590
Jul 30, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$436→$548
Jul 9, 2026	B of A Securities	Joanna Gajuk	PT Raise	Neutral	$450→$510
Apr 27, 2026	RBC Capital	Ben Hendrix	PT Raise	Sector Perform	$422→$436
Feb 27, 2026	RBC Capital	Ben Hendrix	Downgrade	Outperform→Sector Perform	$572→$422
Feb 27, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$580→$500
Jan 22, 2026	Jefferies	Brian Tanquilut	Downgrade	Buy→Hold	$550→$475
Nov 10, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$589→$572
Sep 10, 2025	B of A Securities	Joanna Gajuk	PT Cut	Buy	$610→$595
Sep 2, 2025	Jefferies	Brian Tanquilut	Upgrade	Hold→Buy	$490→$550
Jul 31, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$640→$589
Jul 31, 2025	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$650→$580
Jul 25, 2025	Jefferies	Brian Tanquilut	Initiate	Hold	$500
Jun 30, 2025	RBC Capital	Ben Hendrix	PT Cut	Outperform	$674→$640
Jun 30, 2025	B of A Securities	Joanna Gajuk	PT Cut	Buy	$708→$650

Analyst Ratings News

PRO
RBC Capital Maintains Sector Perform on Chemed, Raises Price Target to $585

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Sector Perform and raises the price target from $548 to $585.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Chemed, Raises Price Target to $675

UBS analyst A.J. Rice maintains Chemed (NYSE:CHE) with a Buy and raises the price target from $650 to $675.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $625

Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $590 to $625.

Benzinga Newsdesk

PRO
Jefferies Upgrades Chemed to Buy, Raises Price Target to $620

Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $520 to $620.

Benzinga Newsdesk

PRO
UBS Initiates Coverage On Chemed with Buy Rating, Announces Price Target of $650

UBS analyst A.J. Rice initiates coverage on Chemed (NYSE:CHE) with a Buy rating and announces Price Target of $650.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Chemed, Raises Price Target to $590

Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and raises the price target from $500 to $590.

Benzinga Newsdesk